Literature DB >> 7690634

Hepatitis C virus antibody in multiply transfused Chinese with thalassaemia major.

Y L Lau1, C B Chow, A C Lee, K W Ng, W L Lim, C F Chan, S Y Lam, C K Li.   

Abstract

Thirty-four of 99 multiply transfused Chinese (49 females, 50 males) with thalassaemia major were positive for antibody to hepatitis C virus. There was no sex predominance in seropositivity with 18 females and 16 males positive. The mean (+/- SD) age and units of blood transfused were significantly higher in the seropositive patients (167 +/- 48 months, 206 +/- 82 units respectively) than the seronegative patients (113 +/- 56 months, 124 +/- 80 units respectively). The seropositive patients had higher mean (+/- SD) serum alanine aminotransferase, aspartate aminotransferase and ferritin concentrations (91 +/- 82 IU/L, 67 +/- 38 IU/L, 4797 +/- 2522 ng/ml respectively) than the seronegative patients (38 +/- 29 IU/L, 48 +/- 28 IU/L, 3620 +/- 2140 ng/ml respectively). Serum ferritin had an independent and significant effect on serum alanine aminotransferase in addition to that of seropositivity to hepatitis C virus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7690634

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

Review 1.  Hepatitis B, C & D viral markers in multitransfused thalassemic children: long-term complications and present management.

Authors:  V P Choudhry; S K Acharya
Journal:  Indian J Pediatr       Date:  1995 Nov-Dec       Impact factor: 1.967

2.  Hepatitis C virus infection in adult Chinese hemophilia patients negative for the human immunodeficiency virus: treatment results with interferon and ribavirin.

Authors:  Wing Y Au; Clarence C K Lam; Chi-Leung Liu; Man-Fung Yuen
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

3.  Assessment Hepatomegaly and liver Enzymes in 100 Patients with beta Thalassemia Major in Mashhad, Iran.

Authors:  H Hashemizadeh; R Noori; Sh Kolagari
Journal:  Iran J Ped Hematol Oncol       Date:  2012-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.